Abstract
Phosphorylated derivatives of phosphatidylinositol (PtdIns), known as phosphoinositides (PIs), are essential regulators of nuclear functions, cytoskeletal dynamics, cell signaling and membrane trafficking. These lipids are found on the cytosolic face of intracellular membranes but can also be detected in membrane-free regions of the nucleoplasm. Their downstream effectors include several proteins that contain various PI-specific domains. Because impaired PI metabolism is associated with disorders such as cancer, cardiovascular disease and immune dysfunction, there is currently great interest in studying PIs and their metabolic enzymes. Here we describe strategies and techniques for quantitative and qualitative measurement of PIs, for characterization of specific PI-binding proteins and for determination of PI kinase and phosphatase activities in vitro and in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
De Matteis, M.A. & Godi, A. PI-loting membrane traffic. Nat. Cell Biol. 6, 487–492 (2004).
Simonsen, A., Wurmser, A.E., Emr, S.D. & Stenmark, H. The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13, 485–492 (2001).
Prestwich, G.D. Phosphoinositide signaling; from affinity probes to pharmaceutical targets. Chem. Biol. 11, 619–637 (2004).
Vanhaesebroeck, B. et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535–602 (2001).
Pendaries, C., Tronchere, H., Plantavid, M. & Payrastre, B. Phosphoinositide signaling disorders in human diseases. FEBS Lett. 546, 25–31 (2003).
Luo, J., Manning, B.D. & Cantley, L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257–262 (2003).
Balla, T. Phosphoinositide-derived messengers in endocrine signaling. J. Endocrinol. 188, 135–153 (2006).
Hammond, G., Thomas, C.L. & Schiavo, G. Nuclear phosphoinositides and their functions. Curr. Top. Microbiol. Immunol. 282, 177–206 (2004).
Lemmon, M.A. Phosphoinositide recognition domains. Traffic 4, 201–213 (2003).
Downes, C.P., Gray, A. & Lucocq, J.M. Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol. 15, 259–268 (2005).
Stenmark, H., Aasland, R. & Driscoll, P.C. The phosphatidylinositol 3-phosphate–binding FYVE finger. FEBS Lett. 513, 77–84 (2002).
Balla, T. Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 118, 2093–2104 (2005).
Balla, T., Bondeva, T. & Várnai, P. How accurately can we image inositol lipids in living cells? Trends Pharmocol. Sci. 21, 238–241 (2000).
Hokin, L.E. & Honkin, M.R. Phosphoinositides and protein secretion in pancreas slices. J. Biol. Chem. 233, 805–810 (1958).
Dove, S.K. et al. Osmotic stress activates phoshatidylinositol-3,5-bisphosphate synthesis. Nature 390, 187–192 (1997).
Shears, S., ed. Signaling by inositides. (Oxford University Press, Oxford, 1997).
Nasuhoglu, C. et al. Nonradioactive analysis of phosphatidylinositides and other anionic phospholipids by anion-exchange high-performance liquid chromatography with suppressed conductivity detection. Anal. Biochem. 301, 243–254 (2002).
Han, X. & Gross, R.W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res. 44, 1071–1079 (2003).
Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198–207 (2003).
Hsu, F.F. & Turk, J. Characterization of phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate by electrospray ionization tandem mass spectrometry: a mechanistic study. J. Am. Soc. Mass Spectrom. 11, 986–999 (2000).
Wenk, M.R. et al. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat. Biotechnol. 21, 813–817 (2003).
Balla, T. & Varnai, P. Visualizing cellular phosphoinositide pools with GFP-fused protein-modules. Sci. STKE 2002, PL3 (2002).
Halet, G. Imaging phosphoinositide dynamics using GFP-tagged protein domains. Biol. Cell. 97, 501–518 (2005).
Gillooly, D.J. et al. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 19, 4577–4588 (2000).
Osborne, S.L., Thomas, C.L., Gschmeissner, S. & Schiavo, G. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J. Cell Sci. 114, 2501–2511 (2001).
Lichtman, J.W. & Conchello, J.A. Fluorescence microscopy. Nat. Methods 2, 910–919 (2005).
Levine, T.P. & Munro, S. Targeting of Golgi-specific pleckstrin homology domains involves both PtdIns 4-kinase–dependent and –independent components. Curr. Biol. 12, 695–704 (2002).
Godi, A. et al. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell Biol. 6, 393–404 (2004).
Krugmann, S. et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95–108 (2002).
Kutateladze, T. & Overduin, M. Structural mechanism of endosome docking by the FYVE domain. Science 291, 1793–1796 (2001).
Dowler, S., Kular, G. & Alessi, D.R. Protein lipid overlay assay. Sci. STKE 2002, PL6 (2002).
Misra, S., Miller, G.J. & Hurley, J.H. Recognizing phosphatidylinositol 3-phosphate. Cell 107, 559–562 (2001).
Schiavo, G., Gu, Q.M., Prestwich, G.D., Söllner, T.H. & Rothman, J.E. Calcium-dependent switching of the specificity of phosphoinositide binding to synaptotagmin. Proc. Natl. Acad. Sci. USA 93, 13327–13332 (1996).
Knodler, A. & Mayinger, P. Analysis of phosphoinositide-binding proteins using liposomes as an affinity matrix. Biotechniques 38, 858, 860, 862 (2005).
Ferguson, C.G. et al. Phosphoinositide-containing polymerized liposomes: stable membrane-mimetic vesicles for protein-lipid binding analysis. Bioconjug. Chem. 16, 1475–1483 (2005).
James, S.R. et al. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem. J. 315, 709–713 (1996).
Sankaran, V.G., Klein, D.E., Sachdeva, M.M. & Lemmon, M.A. High-affinity binding of a FYVE domain to phosphatidylinositol 3-phosphate requires intact phospholipid but not FYVE domain oligomerization. Biochemistry 40, 8581–8587 (2001).
Nahta, R., Hortobagyi, G.N. & Esteva, F.J. Signal transduction inhibitors in the treatment of breast cancer. Curr. Med. Chem. Anticancer Agents 3, 201–216 (2003).
Schu, P.V. et al. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 260, 88–91 (1993).
Odorizzi, G., Babst, M. & Emr, S.D. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95, 847–858 (1998).
Whitman, M., Downes, C.P., Keeler, M., Keller, T. & Cantley, L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332, 644–646 (1988).
Drees, B.E. et al. Competitive fluorescence polarization assays for the detection of phosphoinositide kinase and phosphatase activity. Comb. Chem. High Throughput Screen. 6, 321–330 (2003).
Gray, A., Olsson, H., Batty, I.H., Priganica, L. & Downes, C.P. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313, 234–245 (2003).
Baykov, A.A., Evtushenko, O.A. & Avaeva, S.M. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal. Biochem. 171, 266–270 (1988).
Taylor, G.S. & Dixon, J.E. Assaying phosphoinositide phosphatases. Methods Mol. Biol. 284, 217–227 (2004).
Milligan, G. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein–coupled receptors. Eur. J. Pharm. Sci. 21, 397–405 (2004).
Sato, M., Ueda, Y., Takagi, T. & Umezawa, Y. Production of PtdInsP3 at endomembranes is triggered by receptor endocytosis. Nat. Cell Biol. 5, 1016–1022 (2003).
Hurley, J.H. & Misra, S. Signaling and subcellular targeting by membrane-binding domains. Annu. Rev. Biophys. Biomol. Struct. 29, 49–79 (2000).
Ishikawa, D. & Taki, T. Thin-layer chromatography blotting using polyvinylidene difluoride membrane (far-eastern blotting) and its applications. Methods Enzymol. 312, 145–157 (2000).
Burd, C.G. & Emr, S.D. Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to RING FYVE domains. Mol. Cell 2, 157–162 (1998).
Gaullier, J.M. et al. FYVE fingers bind PtdIns(3)P. Nature 394, 432–433 (1998).
Patki, V., Lawe, D.C., Corvera, S., Virbasius, J.V. & Chawla, A. A functional PtdIns(3)P-binding motif. Nature 394, 433–434 (1998).
Ellson, C.D. et al. Phosphatidylinositol 3-phosphate regulates the neutrophil oxidase complex by binding to the PX domain of p40phox. Nat. Cell Biol. 3, 679–682 (2001).
Kanai, F. et al. The PX domains of p47phox and p40phox bind to lipid products of phosphoinositide 3-kinase. Nat. Cell Biol. 3, 675–678 (2001).
Levine, T.P. & Munro, S. The pleckstrin homology domain of oxysterol-binding protein recognises a determinant specific to Golgi membranes. Curr. Biol. 8, 729–739 (1998).
Dowler, S. et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem. J. 351, 19–31 (2000).
Gozani, O. et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114, 99–111 (2003).
Thomas, C.C., Dowler, S., Deak, M., Alessi, D.R. & van Aalten, D.M. Crystal structure of the phosphatidylinositol 3,4-bisphosphate-binding pleckstrin homology (PH) domain of tandem PH-domain-containing protein 1 (TAPP1): molecular basis of lipid specificity. Biochem. J. 358, 287–294 (2001).
Downes, C.P., Gray, A., Watt, S.A. & Lucocq, J.M. Advances in procedures for the detection and localization of inositol phospholipid signals in cells, tissues, and enzyme assays. Methods Enzymol. 366, 64–84 (2003).
Kimber, W.A. et al. Evidence that the tandem-pleckstrin-homology-domain-containing protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein MUPP1 in vivo. Biochem. J. 361, 525–536 (2002).
Watt, S.A. et al. Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopy. Biochem. J. 377, 653–663 (2004).
Dove, S.K. et al. Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectors. EMBO J. 23, 1922–1933 (2004).
Tsujita, K. et al. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J. Biol. Chem. 279, 13817–13824 (2004).
Friant, S. et al. Ent3p Is a PtdIns(3,5)P2 effector required for protein sorting to the multivesicular body. Dev. Cell 5, 499–511 (2003).
Lemmon, M.A., Ferguson, K.M., O'Brien, R., Sigler, P.B. & Schlessinger, J. Specific and high-affinity binding of inositol phophates to an isolated pleckstrin homology domain. Proc. Natl. Acad. Sci. USA 92, 10472–10476 (1995).
Garcia, P. et al. The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry 34, 16228–16234 (1995).
Kavran, J.M. et al. Specificity and promiscuity in phosphoinositide binding by Pleckstrin homology domains. J. Biol. Chem. 273, 30497–30508 (1998).
Rameh, L.E. et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272, 22059–22066 (1997).
Klarlund, J.K. et al. Regulation of GRP1-catalyzed ADP ribosylation factor guanine nucleotide exchange by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 1859–1862 (1998).
Klarlund, J.K. et al. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275, 1927–1930 (1997).
Venkateswarlu, K., Oatey, P.B., Tavaré, J.M. & Cullen, P.J. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr. Biol. 8, 463–466 (1998).
Britton, J.S., Lockwood, W.K., Li, L., Cohen, S.M. & Edgar, B.A. Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev. Cell 2, 239–249 (2002).
Gillooly, D.J., Raiborg, C. & Stenmark, H. Phosphatidylinositol 3-phosphate is found in microdomains of early endosomes. Histochem. Cell Biol. 120, 445–453 (2003).
Cantley, L.C. The phosphoinositide 3-kinase pathway. Science 296, 1655–1657 (2002).
Dyson, J.M. et al. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Int. J. Biochem. Cell Biol. 37, 2260–2265 (2005).
Kang, S., Bader, A.G., Zhao, L. & Vogt, P.K. Mutated PI 3-kinases: cancer targets on a silver platter. Cell Cycle 4, 578–581 (2005).
Laporte, J. et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13, 175–182 (1996).
Bolino, A. et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25, 17–19 (2000).
Zhang, X., Jefferson, A.B., Auethavekiat, V. & Majerus, P.W. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 92, 4853–4856 (1995).
Li, S. et al. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy. Am. J. Hum. Genet. 77, 54–63 (2005).
Bader, A.G., Kang, S. & Vogt, P.K. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc. Natl. Acad. Sci. USA 103, 1475–1479 (2006).
Kang, S., Bader, A.G. & Vogt, P.K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc. Natl. Acad. Sci. USA 102, 802–807 (2005).
Shayesteh, L. et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99–102 (1999).
Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
Acknowledgements
T.E.R. is a postdoctoral fellow of the Research Council of Norway. We thank the Norwegian Cancer Society and the Novo-Nordisk Foundation for financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rusten, T., Stenmark, H. Analyzing phosphoinositides and their interacting proteins. Nat Methods 3, 251–258 (2006). https://doi.org/10.1038/nmeth867
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth867
This article is cited by
-
Modulation of Kv7 channels and excitability in the brain
Cellular and Molecular Life Sciences (2017)
-
Required hydrophobicity of fluorescent reporters for phosphatidylinositol family of lipid enzymes
Analytical and Bioanalytical Chemistry (2017)
-
Phosphoinositides: Minor Lipids Make a Major Impact on Photoreceptor Cell Functions
Scientific Reports (2014)
-
Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry
Nature Methods (2011)
-
The emerging mechanisms of isoform-specific PI3K signalling
Nature Reviews Molecular Cell Biology (2010)